Motley Fool  Jun 24  Comment 
The FDA has approved its first commercial medicine, and because it could reshape a big indication, the company may have just gotten a lot more interesting to suitors.
SeekingAlpha  Jun 18  Comment 
FierceBiotech  Jun 16  Comment 
Six years after Pfizer's landmark REMOTE trial, Parexel and Sanofi are teaming up in a pilot study to revisit the idea of using wearables in clinical trials.
FiercePharma  Jun 14  Comment 
Having seen Zika’s devastating effects reach Florida residents, a group of lawmakers in the state is urging the Army to pump the brakes on its exclusive vaccine license to Sanofi.
Benzinga  Jun 13  Comment 
TESARO Inc (NASDAQ: TSRO) takeover rumors have been swirling around since September 2016, and Benzinga continues to hear M&A chatter Tuesday. The biopharmaceutical company has been a huge acquisition target, as biotech companies look to gain...
FiercePharma  Jun 12  Comment 
Earlier this month, industry watchers questioned who could swallow the reportedly on-the-block Tesaro and its $7.5 billion-plus market cap. Now, though, it seems a pair of M&A-starved drugmakers may be interested in trying.
FiercePharma  Jun 12  Comment 
Competing with Sanofi blockbuster Lantus is no easy task, but that's exactly what Novo Nordisk's long-acting insulin Tresiba has to do. Thanks to new data, though, the drugmaker can safely say its newcomer poses no increased heart risks—and it...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki